Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5251–5300 of 35157
On January 28, 2025, the Board of Directors (the “Board”) of Kennametal Inc. (the “Company”) announced the appointment of Doug Dietrich, age 55, to serve as a member of the Board of Directors to hold office from February 1, 2025 until the Annual Meeting of Shareholders in October 2025
On January 27, 2025, Candace Matthews, a member of the Board of Directors of MillerKnoll, Inc. (the “Company”) advised the Board that she was resigning from the Board effective February 15, 2025.
elected Richard S. Stoddart to the Board, in each case, effective February 3, 2025.
On January 29, 2025, Bogota Financial Corp. (the “Company”) appointed Peter T. Donnelly to the board of directors of the Company, effective March 26, 2025.
On January 29, 2025, Mr. John C. Gordon, a member of the Board of Directors (the “Board”) of First US Bancshares, Inc. (the “Company”), notified the Company of his resignation as a director of the Company effective January 31, 2025.
On January 24, 2025, Mr. John Wilson resigned from the Board of Directors of Marker Therapeutics, Inc.
On January 27, 2025, Eric Speron resigned as a member of the Company’s Board of Directors and its Compensation Committee, effective as of January 31, 2025.
Troy W. Thacker notified the Company that he has made the decision not to stand for re-election at the 2025 Annual Meetings
appointed Timothy A. Roberts and Bruce E. Cope, CPA to the Board, effective as of January 24, 2025
appointed Timothy A. Roberts and Bruce E. Cope, CPA to the Board, effective as of January 24, 2025
On January 29, 2025, the board of directors of Lantheus Holdings, Inc. (the “Board”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Phuong Khanh (P.K.) Morrow, M.D., an experienced pharmaceutical executive and physician-scientist with deep expertise leading end-to-end clinical development in the field of oncology, to the Board.
each of David V. Goeckeler, Thomas Caulfield and Miyuki Suzuki will resign from their positions as members of the Company’s board of directors
each of David V. Goeckeler, Thomas Caulfield and Miyuki Suzuki will resign from their positions as members of the Company’s board of directors
each of David V. Goeckeler, Thomas Caulfield and Miyuki Suzuki will resign from their positions as members of the Company’s board of directors
the Board unanimously appointed Irving Tan, Bruce Kiddoo and Roxanne Oulman to the Board, effective upon, and subject to, the consummation of the Spin-Off.
the Board unanimously appointed Irving Tan, Bruce Kiddoo and Roxanne Oulman to the Board, effective upon, and subject to, the consummation of the Spin-Off.
the Board unanimously appointed Irving Tan, Bruce Kiddoo and Roxanne Oulman to the Board, effective upon, and subject to, the consummation of the Spin-Off.
Effective January 28, 2025, the Board, upon recommendation by the Committee, appointed Mr. Lyle Wang, age 26, as a director of the Board, in addition to his role as chief financial officer of the Company.
On January 27, 2025, Mr. Neil Hare provided notice of his resignation from the Board of Directors (the “Board”) of Longeveron Inc. (the “Company”) to be effective immediately.
appointed Christopher M. Smith to serve as a Class III director effective January 30, 2025
David Meline, a member of the Board, notified the Company of his resignation from the Board, effective January 30, 2025
On January 28, 2025, Paul J. Hastings, Chair of the Board of Directors (the “Board”), and Andreas Wicki, a member of the Board, each notified the Board of Pacira BioSciences, Inc. (the “Company”) of his respective decision to resign as a member of the Board, in each case, effective immediately
On January 25, 2025, Weiting (Cathy) Feng, a member of the Board and the Chief Financial Officer and Chief Operating Officer of the Company, tendered her resignation to the Company as a member of the Board
Effective on January 29, 2025, immediately following the amendment to the Bylaws discussed below in Item 5.03 , and at the request of the holders of the Company’s Series C Preferred Stock shares (i.e., the Sellers), and as one of the two Series C Preferred Stock designees allowed pursuant to terms of the Company’s Series C Preferred Stock (with Mr. William Scott being the other), as described in greater detail in the April 9, 2024 Form 8-K, the Board of Directors increased the number of members of the Board of Directors from five (5) to six (6) and appointed Snežana Božović, one of the Sellers, and the Secretary of Meridian Bet Group, as a member of the Board of Directors of the Company.
On January 29, 2025, the Board of Directors (the “Board”) of Sprinklr, Inc. (the “Company”) increased the size of the Board from eight to ten directors and, following the recommendation of the Company’s Nominating and Corporate Governance Committee, appointed (i) Jan R. Hauser to serve as a member of the Board as a Class I director, for a term expiring at the Company’s 2025 Annual Meeting of Stockholders
On January 28, 2025, Julie Richardson notified the board of directors (the “Board”) of Yext, Inc. (the “Company”) that, after nearly 10 years of service to the Company, she intended to resign as a member of the Board, effective at the conclusion of the Company's current fiscal year on January 31, 2025.
On January 28, 2025, Mr. Mann resigned as a member of the Board.
Effective January 24, 2025, Nixxy, Inc. (the “Company”) appointed Christopher Mann as a member of the Board of Directors (the “Board”).
the Board appointed Andrew Q. Kraft as a director of the Company to fill the Director Vacancy
On January 28, 2025, Vern Lund informed Texas Mineral Resources Corp. (“Company”) of his decision to resign as a director effective that date (including his decision not to stand for re-election to the Board at the next annual meeting of stockholders), due to the potential delay in the development of the Round Top project
On January 28, 2025, Peter Denetclaw, Jr. informed the Company of his decision to resign as a director effective that date (including his decision not to stand for re-election to the Board at the next annual meeting of stockholders), due to the potential delay in the development of the Round Top project
On January 27, 2025, Patricia Little informed the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of McCormick & Company, Incorporated (the “Registrant”) that she intends to retire from the Board of the Registrant and will not stand for election at the Registrant’s next annual stockholders’ meeting, which is currently scheduled for March 26, 2025.
appointed Maria N. Martinez to serve on the Board
On January 28, 2025, Dr. Diane S.L. Paloma was appointed to the Boards of Directors of Central Pacific Financial Corp. (the "Company") and Central Pacific Bank (the "Bank"), to be effective January 28, 2025.
On January 28, 2025, the Board of Directors (the "Board") of Carlisle Companies Incorporated (the “Company”) elected Sheryl D. Palmer to the Board, effective that day, as part of the class with a term expiring at the Company's 2026 annual meeting of stockholders
On January 23, 2025, Sam Wadsworth, Ph.D., notified Precision BioSciences, Inc. (the “Company”) of his intention to retire from service on company boards and resigned from the Company’s Board of Directors.
On January 28, 2025, the Board of Directors (the “Board”) of Artiva Biotherapeutics, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Daniel Baker, Ph.D. as (i) a Class I director of the Company, with a term of office expiring at the 2025 annual meeting of stockholders
Jeffrey A. Miller was appointed as a director of the Company.
the Board appointed Adele M. Gulfo as a director of the Board, filling the Class I vacancy on the Board resulting from Ms. Kjellson’s resignation.
Nina Kjellson resigned from the Board and the Compensation Committee of the Board effective as of January 29, 2025
On January 27, 2025, Robert J. Hombach was appointed to the Board as a director.
On January 26, 2025, the Board of Directors (the “Board”) of Dynavax Technologies Corporation (the “Company”) appointed (i) Lauren Silvernail to serve as a Class I Director, to serve until the 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) and (ii) Emilio Emini, Ph.D. to serve as a Class III Director, to serve until the 2027 Annual Meeting of Stockholders, in each case effective as of February 3, 2025
On January 26, 2025, Peggy V. Phillips, a member of the Board, notified the Company that she will be retiring from the Board, effective immediately prior to the 2025 Annual Meeting.
On January 26, 2025, Julie Eastland, a member of the Board, notified the Company that she will be resigning from the Board, effective immediately prior to the 2025 Annual Meeting.
On January 26, 2025, the Board of Directors (the “Board”) of Dynavax Technologies Corporation (the “Company”) appointed (i) Lauren Silvernail to serve as a Class I Director, to serve until the 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) and (ii) Emilio Emini, Ph.D. to serve as a Class III Director, to serve until the 2027 Annual Meeting of Stockholders, in each case effective as of February 3, 2025
On January 28, 2025, Alan G. Spoon notified the Board of Directors (the “Board”) of Fortive Corporation (the “Company”) that he has elected not to stand for re-election as a director at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”) to be held on June 3, 2025, and will retire from the Board effective on the date of the Annual Meeting.
On January 28, 2025, Karim Galzahr was elected to the Company’s board of directors.
the Company has appointed Mr. Roger C. Kennedy, the Purchaser’s designee, to the Board as a non-executive director
appointed Johnny Dossey as a Cottonmouth Director (as defined in the A&R Charter), effective as of the same date
approved an increase to the number of members of the Board from seven (7) to eight (8) and elected Amir Faintuch to serve as an independent member of the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.